CAH SEC filings (2026)
CIK 721371 · Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122) · incorporated in OH · fiscal year ends in June
2,609 filings on EDGAR since 1994 · 37 annual, 99 quarterly, 374 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
October 2026
- Oct 18-K8-K · Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS HealthRegulation FD disclosure
September 2026
- Sep 21ProxyProxy · Annual report to shareholders
- Sep 21ProxyProxy · Additional proxy materials
- Sep 21ProxyProxy · Proxy statement
August 2026
- Aug 19Insider saleHollar Jason M. (Chief Executive Officer) sold 44,529 shares for $10.5M at $233.22–$237.88
- Aug 19Insider saleScherer Mary C. (Chief Accounting Officer) sold 2,302 shares for $546K at $237.39–$237.40
- Aug 18Insider saleHollar Jason M. (Chief Executive Officer) sold 80,000 shares for $18.9M at $234.56–$237.25
- Aug 18Insider saleAlt Aaron E (Chief Financial Officer) sold 42,000 shares for $9.9M at $234.55–$237.26
- Aug 18Insider saleMason Stephen M (CEO, GMPD Segment) sold 35,000 shares for $8.3M at $234.59–$237.26
- Aug 18Insider saleMayer Jessica L (Chief Legal/Compliance Officer) sold 29,436 shares for $7.0M at $234.64–$237.31
- Aug 18Insider saleGreene Michelle D. (Chief Information Officer) sold 11,650 shares for $2.7M at $234.57–$237.25
- Aug 18Insider saleWEITZMAN DEBORAH (CEO, PSS Segment) sold 7,354 shares for $1.7M at $235.30–$237.44
- Aug 11EarningsEarnings release — EPS $2.91 vs $2.42 est. (+20.3%); revenue $63.67B (+6% y/y) 1.3%
- Aug 11ReportAnnual report, FY2026 — revenue $254.25B (+14% y/y), net income $1.71B, EPS $7.23
- Aug 118-K8-K · Material definitive agreement; Termination of a material agreement; New financial obligation
- Aug 58-K8-K · Directors or officers; compensation
April 2026
March 2026
- Mar 238-K8-K · Cardinal Health Appoints Patricia A. Hemingway Hall as Board ChairDirectors or officers; compensation; Regulation FD disclosure
- Mar 58-K8-K · Directors or officers; compensation
February 2026
- Feb 27Insider saleGreene Michelle D. (Chief Information Officer) sold 2,746 shares for $627K at $228.47–$228.55
- Feb 18Insider saleAlt Aaron E (Chief Financial Officer) sold 2,328 shares for $525K at $225.50
- Feb 6Insider saleHall Patricia Hemingway (Director) sold 4,000 shares for $919K at $229.72
- Feb 5EarningsEarnings release — EPS $2.63 vs $2.39 est. (+10.0%); revenue $65.63B (+19% y/y) 9.8%
- Feb 5ReportQuarterly report, Q2 FY2026 — revenue $65.63B (+19% y/y), net income $467.0M
January 2026
- Jan 138-K8-K · Cardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference PresentationRegulation FD disclosure
November 2025
- Nov 68-K8-K · Shareholder vote results
October 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $61.6M in 11 sales and bought nothing on the open market; 27 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Aug 19, 2026Form 4 | Hollar Jason M.Chief Executive OfficerSold · $10.5M · 44,529 sh |
| Aug 19, 2026Form 4 | Scherer Mary C.Chief Accounting OfficerSold · $546K · 2,302 sh |
| Aug 18, 2026Form 4 | Hollar Jason M.Chief Executive OfficerSold · $18.9M · 80,000 sh |
| Aug 18, 2026Form 4 | Alt Aaron EChief Financial OfficerSold · $9.9M · 42,000 sh |
| Aug 18, 2026Form 4 | Mason Stephen MCEO, GMPD SegmentSold · $8.3M · 35,000 sh |
| Aug 18, 2026Form 4 | Mayer Jessica LChief Legal/Compliance OfficerSold · $7.0M · 29,436 sh |
| Aug 18, 2026Form 4 | Greene Michelle D.Chief Information OfficerSold · $2.7M · 11,650 sh |
| Aug 18, 2026Form 4 | WEITZMAN DEBORAHCEO, PSS SegmentSold · $1.7M · 7,354 sh |
| Feb 27, 2026Form 4 | Greene Michelle D.Chief Information OfficerSold · $627K · 2,746 sh |
| Feb 18, 2026Form 4 | Alt Aaron EChief Financial OfficerSold · $525K · 2,328 sh |
| Feb 6, 2026Form 4 | Hall Patricia HemingwayDirectorSold · $919K · 4,000 sh |
Awards, exercises, withholding and plan purchases · 27 transactions
| Date | Insider |
|---|---|
| Aug 15, 2026Form 4 | Hollar Jason M.Chief Executive OfficerTax withholding · $24.3M · 103,449 sh |
| Aug 15, 2026Form 4 | Alt Aaron EChief Financial OfficerTax withholding · $7.2M · 30,730 sh |
| Aug 15, 2026Form 4 | WEITZMAN DEBORAHCEO, PSS SegmentTax withholding · $7.0M · 29,759 sh |
| Aug 15, 2026Form 4 | Mason Stephen MCEO, GMPD SegmentTax withholding · $5.9M · 25,289 sh |
| Aug 15, 2026Form 4 | Mayer Jessica LChief Legal/Compliance OfficerTax withholding · $5.9M · 25,285 sh |
| Aug 15, 2026Form 4 | Greene Michelle D.Chief Information OfficerTax withholding · $2.4M · 10,031 sh |
| Aug 15, 2026Form 4 | Pitteroff Valerie ChristineChief Human Resources OfficerTax withholding · $436K · 1,852 sh |
| Aug 15, 2026Form 4 | Scherer Mary C.Chief Accounting OfficerTax withholding · $413K · 1,757 sh |
| Aug 15, 2026Form 4 | Hollar Jason M.Chief Executive OfficerAward · $0 · 30,616 sh |
| Aug 15, 2026Form 4 | Alt Aaron EChief Financial OfficerAward · $0 · 8,079 sh |
| Aug 15, 2026Form 4 | WEITZMAN DEBORAHCEO, PSS SegmentAward · $0 · 7,314 sh |
| Aug 15, 2026Form 4 | Mayer Jessica LChief Legal/Compliance OfficerAward · $0 · 6,378 sh |
| Aug 15, 2026Form 4 | Mason Stephen MCEO, GMPD SegmentAward · $0 · 5,868 sh |
| Aug 15, 2026Form 4 | Pitteroff Valerie ChristineChief Human Resources OfficerAward · $0 · 2,977 sh |
| Aug 15, 2026Form 4 | Greene Michelle D.Chief Information OfficerAward · $0 · 2,551 sh |
| Aug 15, 2026Form 4 | Scherer Mary C.Chief Accounting OfficerAward · $0 · 765 sh |
| Aug 4, 2026Form 4 | Hollar Jason M.Chief Executive OfficerAward · $0 · 187,965 sh |
| Aug 4, 2026Form 4 | Alt Aaron EChief Financial OfficerAward · $0 · 58,738 sh |
| Aug 4, 2026Form 4 | WEITZMAN DEBORAHCEO, PSS SegmentAward · $0 · 54,823 sh |
| Aug 4, 2026Form 4 | Mason Stephen MCEO, GMPD SegmentAward · $0 · 46,992 sh |
| Aug 4, 2026Form 4 | Mayer Jessica LChief Legal/Compliance OfficerAward · $0 · 46,992 sh |
| Aug 4, 2026Form 4 | Greene Michelle D.Chief Information OfficerAward · $0 · 17,230 sh |
| Aug 4, 2026Form 4 | Scherer Mary C.Chief Accounting OfficerAward · $0 · 2,610 sh |
| Aug 4, 2026Form 4 | Pitteroff Valerie ChristineChief Human Resources OfficerAward · $0 · 2,610 sh |
| Apr 15, 2026Form 4 | Hall Patricia HemingwayDirectorAward · $79K · 381 sh |
| Feb 15, 2026Form 4 | Alt Aaron EChief Financial OfficerTax withholding · $423K · 1,914 sh |
| Jan 15, 2026Form 4 | Pitteroff Valerie ChristineChief Human Resources OfficerAward · $849K · 3,982 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 15 filings
| Filed | What it is |
|---|---|
| Oct 1, 20268-K | Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS HealthRegulation FD disclosure |
| Sep 21, 2026ARS | Annual report to shareholders |
| Sep 21, 2026DEFA14A | Additional proxy materials |
| Sep 21, 2026DEF 14A | Proxy statement |
| Aug 11, 202610-K | Annual report, FY2026 — revenue $254.25B (+14% y/y), net income $1.71B, EPS $7.23 |
| Aug 11, 20268-K | Earnings release — EPS $2.91 vs $2.42 est. (+20.3%); revenue $63.67B (+6% y/y) 1.3% |
| Aug 11, 20268-K | Material definitive agreement; Termination of a material agreement; New financial obligation |
| Aug 5, 20268-K | Directors or officers; compensation |
| Apr 30, 202610-Q | Quarterly report, Q3 2026 — revenue $60.94B (+11% y/y), net income $399.0M |
| Apr 30, 20268-K | Earnings release — EPS $3.17 vs $2.80 est. (+13.2%); revenue $60.94B (+11% y/y) 4.9% |
| Mar 23, 20268-K | Cardinal Health Appoints Patricia A. Hemingway Hall as Board ChairDirectors or officers; compensation; Regulation FD disclosure |
| Mar 5, 20268-K | Directors or officers; compensation |
| Feb 5, 202610-Q | Quarterly report, Q2 FY2026 — revenue $65.63B (+19% y/y), net income $467.0M |
| Feb 5, 20268-K | Earnings release — EPS $2.63 vs $2.39 est. (+10.0%); revenue $65.63B (+19% y/y) 9.8% |
| Jan 13, 20268-K | Cardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference PresentationRegulation FD disclosure |
2025 · 19 filings
| Filed | What it is |
|---|---|
| Nov 6, 20258-K | Shareholder vote results |
| Oct 30, 202510-Q | Quarterly report, Q1 FY2026 — revenue $64.01B (+22% y/y), net income $450.0M, EPS $1.88 |
| Oct 30, 20258-K | Earnings release — EPS $2.55 vs $2.21 est. (+15.4%); revenue $64.01B (+22% y/y) 15.4% |
| Oct 10, 20258-K | Material definitive agreement |
| Oct 3, 20258-K | Material definitive agreement |
| Sep 16, 2025ARS | Annual report to shareholders |
| Sep 16, 2025DEFA14A | Additional proxy materials |
| Sep 16, 2025DEF 14A | Proxy statement |
| Aug 27, 20258-K | Material definitive agreement; New financial obligation |
| Aug 14, 20258-K | Other events |
| Aug 12, 202510-K | Annual report, FY2025 — revenue $222.58B (−2% y/y), net income $1.56B, EPS $6.45 |
| Aug 12, 20258-K | Earnings release — EPS $2.08 vs $2.03 est. (+2.5%); revenue $60.16B (+0% y/y) 7.2% |
| Jun 12, 20258-K | Regulation FD disclosure |
| May 1, 202510-Q | Quarterly report, Q3 2025 — revenue $54.88B (+0% y/y), net income $506.0M |
| May 1, 20258-K | Earnings release — EPS $2.35 vs $2.15 est. (+9.3%); revenue $54.88B (+0% y/y) 3.0% |
| Mar 10, 20258-K | Directors or officers; compensation; Regulation FD disclosure |
| Jan 30, 202510-Q | Quarterly report, Q2 FY2025 — revenue $55.26B (−4% y/y), net income $400.0M |
| Jan 30, 20258-K | Earnings release — EPS $1.93 vs $1.75 est. (+10.3%); revenue $55.26B (−4% y/y) |
| Jan 14, 20258-K | Regulation FD disclosure |
2024 · 25 filings
| Filed | What it is |
|---|---|
| Dec 9, 20248-K | Material definitive agreement; New financial obligation |
| Nov 22, 20248-K | Material definitive agreement; Termination of a material agreement; New financial obligation |
| Nov 18, 20248-K | Other events |
| Nov 12, 20248-K | Material definitive agreement; Regulation FD disclosure |
| Nov 7, 20248-K | Shareholder vote results |
| Nov 1, 202410-Q | Quarterly report, Q1 FY2025 — revenue $52.28B (−4% y/y), net income $416.0M, EPS $1.70 |
| Nov 1, 20248-K | Earnings release — EPS $1.88 vs $1.64 est. (+14.6%); revenue $52.28B (−4% y/y) 7.0% |
| Oct 23, 2024DEFA14A | Additional proxy materials |
| Oct 10, 20248-K | Material definitive agreement; New financial obligation |
| Oct 2, 2024DEFA14A | Additional proxy materials |
| Sep 16, 2024ARS | Annual report to shareholders |
| Sep 16, 2024DEFA14A | Additional proxy materials |
| Sep 16, 2024DEF 14A | Proxy statement |
| Sep 9, 20248-K | Directors or officers; compensation |
| Aug 14, 202410-K | Annual report, FY2024 — revenue $226.83B (+11% y/y), net income $852.0M, EPS $3.45 |
| Aug 14, 20248-K | Earnings release — EPS $1.84 vs $1.72 est. (+7.0%); revenue $59.87B (+12% y/y) 3.7% |
| May 2, 202410-Q | Quarterly report, Q3 2024 — revenue $54.87B (+9% y/y), net income $261.0M, EPS $1.07 |
| May 2, 20248-K | Earnings release — EPS $2.08 vs $1.95 est. (+6.7%); revenue $54.87B (+9% y/y) 0.8% |
| Apr 23, 20248-K | Regulation FD disclosure |
| Apr 22, 20248-K | Regulation FD disclosure |
| Feb 28, 20248-K | Directors or officers; compensation; Regulation FD disclosure |
| Feb 20, 20248-K | Material definitive agreement; New financial obligation; Other events |
| Feb 1, 202410-Q | Quarterly report, Q2 FY2024 — revenue $57.44B (+12% y/y), net income $368.0M, EPS $1.50 |
| Feb 1, 20248-K | Earnings release — EPS $1.82 vs $1.56 est. (+16.7%); revenue $57.44B (+12% y/y) 3.7% |
| Jan 9, 20248-K | Results of operations; Regulation FD disclosure |
2023 · 18 filings — 9 × 8-K, 3 × 10-Q, 3 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Nov 3, 202310-Q | Quarterly report, Q1 FY2024 — revenue $54.65B (+10% y/y), net income −$12.0M, EPS −$0.05 |
| Oct 12, 2023DEFA14A | Additional proxy materials |
| Oct 10, 2023DEFA14A | Additional proxy materials |
| Sep 27, 2023ARS | Annual report to shareholders |
| Sep 27, 2023DEFA14A | Additional proxy materials |
| Sep 27, 2023DEF 14A | Proxy statement |
| Aug 15, 202310-K | Annual report, FY2023 — revenue $204.98B (+13% y/y), net income $330.0M, EPS $1.26 |
| May 4, 202310-Q | Quarterly report, Q3 2023 — revenue $50.50B (+13% y/y), net income $365.0M, EPS $1.41 |
| Feb 2, 202310-Q | Quarterly report, Q2 FY2023 — revenue $51.47B (+13% y/y), net income −$77.0M, EPS −$0.30 |
9 current reports (8-K) not listed; the year is on EDGAR.
2022 · 20 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 4, 202210-Q | Quarterly report, Q1 FY2023 — revenue $49.59B (+13% y/y), net income $98.0M, EPS $0.36 |
| Sep 28, 2022DEFA14A | Additional proxy materials |
| Sep 28, 2022DEF 14A | Proxy statement |
| Aug 11, 202210-K | Annual report, FY2022 — revenue $181.33B (+12% y/y), net income −$938.0M, EPS −$3.37 |
| May 5, 202210-Q | Quarterly report, Q3 2022 — revenue $44.84B (+14% y/y), net income −$1.39B |
| Feb 3, 202210-Q | Quarterly report, Q2 FY2022 — revenue $45.46B (+9% y/y), net income $49.0M |
14 current reports (8-K) not listed; the year is on EDGAR.
2021 · 17 filings — 9 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Nov 9, 202110-Q | Quarterly report, Q1 FY2022 — revenue $43.97B (+13% y/y), net income $271.0M, EPS $0.94 |
| Oct 25, 2021DEFA14A | Additional proxy materials |
| Sep 23, 2021DEFA14A | Additional proxy materials |
| Sep 23, 2021DEF 14A | Proxy statement |
| Sep 10, 2021PRE 14A | Preliminary proxy statement |
| Aug 16, 202110-K | Annual report, FY2021 — revenue $162.47B (+6% y/y), net income $611.0M, EPS $2.08 |
| May 6, 202110-Q | Quarterly report, Q3 2021 — revenue $39.27B (+0% y/y), net income $119.0M |
| Feb 5, 202110-Q | Quarterly report, Q2 FY2021 — revenue $41.54B (+5% y/y), net income $629.0M |
9 current reports (8-K) not listed; the year is on EDGAR.
2020 · 19 filings — 9 × 8-K, 3 × 10-Q, 2 × PX14A6G and 5 other forms
| Filed | What it is |
|---|---|
| Nov 5, 202010-Q | Quarterly report, Q1 FY2021 — revenue $39.06B (+5% y/y), net income −$253.0M, EPS −$0.86 |
| Oct 23, 2020PX14A6G | Shareholder exempt solicitation |
| Oct 19, 2020PX14A6G | Shareholder exempt solicitation |
| Sep 23, 2020DEFA14A | Additional proxy materials |
| Sep 23, 2020DEF 14A | Proxy statement |
| Sep 8, 2020PRE 14A | Preliminary proxy statement |
| Aug 13, 202010-K | Annual report, FY2020 — revenue $152.92B (+5% y/y), net income −$3.70B, EPS −$12.61 |
| May 11, 202010-Q | Quarterly report, Q3 2020 — revenue $39.16B (+11% y/y), net income $350.0M |
| Feb 6, 202010-Q | Quarterly report, Q2 FY2020 — revenue $39.73B (+5% y/y), net income $220.0M |
10 current reports (8-K) not listed; the year is on EDGAR.
2019 · 19 filings — 11 × 8-K, 3 × 10-Q, 2 × PX14A6G and 3 other forms
| Filed | What it is |
|---|---|
| Nov 7, 201910-Q | Quarterly report, Q1 FY2020 — revenue $37.34B (+6% y/y), net income −$4.92B, EPS −$16.65 |
| Nov 4, 2019PX14A6G | Shareholder exempt solicitation |
| Oct 4, 2019PX14A6G | Shareholder exempt solicitation |
| Sep 20, 2019DEFA14A | Additional proxy materials |
| Sep 20, 2019DEF 14A | Proxy statement |
| Aug 20, 201910-K | Annual report, FY2019 — revenue $145.53B (+6% y/y), net income $1.36B, EPS $4.53 |
| May 9, 201910-Q | Quarterly report, Q3 2019 — revenue $35.23B (+5% y/y), net income $296.0M |
| Feb 7, 201910-Q | Quarterly report, Q2 FY2019 — revenue $37.74B (+7% y/y), net income $280.0M |
11 current reports (8-K) not listed; the year is on EDGAR.
2018 · 18 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Nov 8, 201810-Q | Quarterly report, Q1 FY2019 — revenue $35.21B (+8% y/y), net income $593.0M, EPS $1.94 |
| Oct 18, 2018PX14A6G | Shareholder exempt solicitation |
| Sep 26, 2018DEFA14A | Additional proxy materials |
| Sep 26, 2018DEF 14A | Proxy statement |
| Aug 22, 201810-K | Annual report, FY2018 — revenue $136.81B (+5% y/y), net income $256.0M, EPS $0.81 |
| May 9, 201810-Q | Quarterly report, Q3 2018 — revenue $33.63B (+6% y/y), net income $255.0M |
| Feb 8, 201810-Q | Quarterly report, Q2 FY2018 — revenue $35.19B (+6% y/y), net income $1.05B |
11 current reports (8-K) not listed; the year is on EDGAR.
2017 · 27 filings — 12 × 8-K, 7 × PX14A6G, 3 × 10-Q and 3 other forms
| Filed | What it is |
|---|---|
| Nov 8, 2017PX14A6G | Shareholder exempt solicitation |
| Nov 7, 201710-Q | Quarterly report, Q1 FY2018 — revenue $32.64B (+2% y/y), net income $115.0M |
| Nov 7, 2017PX14A6G | Shareholder exempt solicitation |
| Nov 6, 2017DEFA14A | Additional proxy materials |
| Nov 1, 2017PX14A6G | Shareholder exempt solicitation |
| Oct 31, 2017PX14A6G | Shareholder exempt solicitation |
| Oct 27, 2017PX14A6G | Shareholder exempt solicitation |
| Oct 23, 2017DEFA14A | Additional proxy materials |
| Oct 18, 2017PX14A6G | Shareholder exempt solicitation |
| Oct 13, 2017PX14A6G | Shareholder exempt solicitation |
| Sep 21, 2017DEFA14A | Additional proxy materials |
| Sep 21, 2017DEF 14A | Proxy statement |
| Aug 10, 201710-K | Annual report, FY2017 — revenue $129.98B (+7% y/y), net income $1.29B, EPS $4.03 |
| May 2, 201710-Q | Quarterly report, Q3 2017 — revenue $31.82B (+4% y/y), net income $381.0M |
| Feb 7, 201710-Q | Quarterly report, Q2 FY2017 — revenue $33.15B (+5% y/y), net income $324.0M |
12 current reports (8-K) not listed; the year is on EDGAR.
2016 · 13 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2015 · 20 filings — 11 × 8-K, 3 × 10-Q, 2 × 8-K/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2014 · 18 filings — 10 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
Counted, not listed; the year is on EDGAR.
2013 · 21 filings — 12 × 8-K, 3 × 10-Q, 2 × 8-K/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2012 · 21 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2011 · 15 filings — 6 × 8-K, 3 × 10-Q, 2 × DEFA14A and 4 other forms
Counted, not listed; the year is on EDGAR.
2010 · 23 filings — 12 × 8-K, 3 × 10-Q, 2 × DEFA14A and 6 other forms
Counted, not listed; the year is on EDGAR.
2009 · 41 filings — 29 × 8-K, 3 × 10-Q, 2 × DEF 14A and 6 other forms
Counted, not listed; the year is on EDGAR.
2008 · 24 filings — 16 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2007 · 39 filings — 27 × 8-K, 4 × 8-K/A, 3 × 10-Q and 5 other forms
Counted, not listed; the year is on EDGAR.
2006 · 26 filings — 19 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2005 · 32 filings — 23 × 8-K, 3 × 10-Q, 1 × 10-K and 5 other forms
Counted, not listed; the year is on EDGAR.
2004 · 23 filings — 18 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2003 · 11 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2002 · 11 filings — 5 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2001 · 10 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K405 and 3 other forms
Counted, not listed; the year is on EDGAR.
2000 · 7 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 2 other forms
Counted, not listed; the year is on EDGAR.
1999 · 9 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
1998 · 18 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K/A and 6 other forms
Counted, not listed; the year is on EDGAR.
1997 · 11 filings — 5 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
1996 · 12 filings — 4 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
1995 · 9 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
1994 · 8 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 48 filings — 28 × 4, 11 × 144, 3 × SCHEDULE 13G and 4 other forms
| Filed | What it is |
|---|---|
| Aug 20, 20264 | Insider transaction (Form 4) |
| Aug 20, 20264 | Insider transaction (Form 4) |
| Aug 20, 20264 | Insider transaction (Form 4) |
| Aug 20, 20264 | Insider transaction (Form 4) |
| Aug 20, 20264 | Insider transaction (Form 4) |
| Aug 20, 20264 | Insider transaction (Form 4) |
| Aug 20, 20264 | Insider transaction (Form 4) |
| Aug 19, 2026144 | Notice of proposed sale (Form 144) |
| Aug 18, 2026144 | Notice of proposed sale (Form 144) |
| Aug 18, 2026144 | Notice of proposed sale (Form 144) |
| Aug 18, 2026144 | Notice of proposed sale (Form 144) |
| Aug 18, 2026144 | Notice of proposed sale (Form 144) |
| Aug 18, 2026144 | Notice of proposed sale (Form 144) |
| Aug 18, 2026144 | Notice of proposed sale (Form 144) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 13, 2026SCHEDULE 13G | Other filings |
| Aug 6, 20264 | Insider transaction (Form 4) |
| Aug 6, 20264 | Insider transaction (Form 4) |
The newest 25 of 48 shown; the full year is on EDGAR.
2025 · 63 filings — 42 × 4, 8 × 144, 2 × 11-K and 8 other forms
| Filed | What it is |
|---|---|
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Dec 2, 20254 | Insider transaction (Form 4) |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Nov 6, 20254 | Insider transaction (Form 4) |
| Oct 17, 2025SCHEDULE 13G | Other filings |
| Aug 20, 2025144 | Notice of proposed sale (Form 144) |
| Aug 20, 20254 | Insider transaction (Form 4) |
| Aug 20, 20254 | Insider transaction (Form 4) |
| Aug 19, 20254 | Insider transaction (Form 4) |
| Aug 19, 20254 | Insider transaction (Form 4) |
| Aug 19, 20254 | Insider transaction (Form 4) |
| Aug 19, 20254 | Insider transaction (Form 4) |
| Aug 19, 20254 | Insider transaction (Form 4) |
The newest 25 of 63 shown; the full year is on EDGAR.
2024 · 61 filings — 35 × 4, 9 × 144, 4 × SC 13G/A and 7 other forms
| Filed | What it is |
|---|---|
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Nov 18, 20244 | Insider transaction (Form 4) |
| Nov 15, 2024424B5 | Prospectus supplement |
| Nov 14, 20244 | Insider transaction (Form 4) |
| Nov 13, 2024FWP | Free writing prospectus |
| Nov 13, 2024424B3 | Prospectus |
| Nov 7, 20244 | Insider transaction (Form 4) |
| Nov 7, 20244 | Insider transaction (Form 4) |
| Nov 7, 20244 | Insider transaction (Form 4) |
| Nov 7, 20244 | Insider transaction (Form 4) |
| Nov 7, 20244 | Insider transaction (Form 4) |
| Nov 7, 20244 | Insider transaction (Form 4) |
| Nov 7, 20244 | Insider transaction (Form 4) |
| Nov 7, 20244 | Insider transaction (Form 4) |
| Nov 7, 20244 | Insider transaction (Form 4) |
| Nov 7, 2024S-8 POS | Other filings |
| Nov 7, 2024S-8 POS | Other filings |
| Nov 7, 2024S-8 POS | Other filings |
| Oct 24, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Aug 22, 20244 | Insider transaction (Form 4) |
| Aug 21, 2024144 | Notice of proposed sale (Form 144) |
| Aug 19, 20244 | Insider transaction (Form 4) |
The newest 25 of 61 shown; the full year is on EDGAR.
2023 · 55 filings — 35 × 4, 10 × 144, 5 × SC 13G/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2022 · 64 filings — 47 × 4, 7 × 3, 3 × SC 13G/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2021 · 55 filings — 46 × 4, 3 × SC 13G/A, 2 × 11-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2020 · 57 filings — 46 × 4, 4 × 3, 2 × 11-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2019 · 59 filings — 42 × 4, 6 × 3, 4 × SC 13G/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2018 · 55 filings — 41 × 4, 5 × 3, 4 × SC 13G/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2017 · 68 filings — 46 × 4, 3 × NO ACT, 3 × S-8 POS and 10 other forms
Counted, not listed; the year is on EDGAR.
2016 · 54 filings — 42 × 4, 5 × SC 13G/A, 2 × 11-K and 5 other forms
Counted, not listed; the year is on EDGAR.
2015 · 71 filings — 54 × 4, 3 × S-8 POS, 3 × SC 13G/A and 7 other forms
Counted, not listed; the year is on EDGAR.
2014 · 104 filings — 67 × 4, 23 × S-8 POS, 4 × SC 13G/A and 6 other forms
Counted, not listed; the year is on EDGAR.
2013 · 87 filings — 72 × 4, 4 × SC 13G/A, 2 × 11-K and 8 other forms
Counted, not listed; the year is on EDGAR.
2012 · 71 filings — 49 × 4, 5 × SC 13G/A, 3 × 5 and 9 other forms
Counted, not listed; the year is on EDGAR.
2011 · 71 filings — 62 × 4, 4 × SC 13G/A, 2 × 11-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2010 · 83 filings — 62 × 4, 4 × SC 13G, 3 × 11-K and 11 other forms
Counted, not listed; the year is on EDGAR.
2009 · 119 filings — 89 × 4, 8 × 3, 5 × SC TO-I/A and 10 other forms
Counted, not listed; the year is on EDGAR.
2008 · 100 filings — 63 × 4, 7 × UPLOAD, 5 × 4/A and 12 other forms
Counted, not listed; the year is on EDGAR.
2007 · 106 filings — 74 × 4, 5 × 3, 4 × CORRESP and 12 other forms
Counted, not listed; the year is on EDGAR.
2006 · 108 filings — 79 × 4, 4 × SC 13G/A, 4 × UPLOAD and 11 other forms
Counted, not listed; the year is on EDGAR.
2005 · 106 filings — 84 × 4, 5 × 3, 3 × 11-K and 11 other forms
Counted, not listed; the year is on EDGAR.
2004 · 98 filings — 73 × 4, 4 × 11-K, 4 × SC TO-T/A and 12 other forms
Counted, not listed; the year is on EDGAR.
2003 · 54 filings — 36 × 4, 3 × 11-K, 3 × 11-KT and 8 other forms
Counted, not listed; the year is on EDGAR.
2002 · 47 filings — 20 × 425, 5 × 11-K, 5 × SC TO-T/A and 10 other forms
Counted, not listed; the year is on EDGAR.
2001 · 19 filings — 4 × 424B5, 3 × 11-K, 3 × S-8 and 7 other forms
Counted, not listed; the year is on EDGAR.
2000 · 10 filings — 3 × S-8, 2 × 11-K, 2 × 425 and 3 other forms
Counted, not listed; the year is on EDGAR.
1999 · 14 filings — 7 × S-8, 3 × SC 13G/A, 1 × 11-K and 3 other forms
Counted, not listed; the year is on EDGAR.
1998 · 20 filings — 4 × S-4/A, 3 × S-4, 2 × 424B3 and 8 other forms
Counted, not listed; the year is on EDGAR.
1997 · 13 filings — 3 × 424B3, 2 × S-4, 2 × S-8 POS and 6 other forms
Counted, not listed; the year is on EDGAR.
1996 · 14 filings — 4 × 424B5, 3 × SC 13D, 2 × S-4 and 4 other forms
Counted, not listed; the year is on EDGAR.
1995 · 17 filings — 6 × SC 13G/A, 3 × S-3/A, 2 × S-8 POS and 6 other forms
Counted, not listed; the year is on EDGAR.
1994 · 19 filings — 3 × S-8, 2 × 10-C, 2 × 424B1 and 10 other forms
Counted, not listed; the year is on EDGAR.
About this data#
Cardinal Health Inc. (CAH) has 2,609 filings on EDGAR going back to 1994: 37 annual reports, 99 quarterly reports and 374 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Aug 11, 2026 for the fiscal year ended Jun 30, 2026. The most recent 8-K, on Oct 1, 2026, furnished a press release headed “Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health”. Over the last 13 months insiders sold $61.6M in 11 sales and bought nothing on the open market; 27 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Cardinal Health Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read CAH's latest 10-K?
- CAH's latest annual report, a 10-K, was filed on Aug 11, 2026 for the fiscal year ended Jun 30, 2026. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did CAH last file an 8-K?
- On Oct 1, 2026 it furnished a press release headed “Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health”. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 11, 2026.
- Are CAH insiders buying or selling?
- Over the last 13 months insiders sold $61.6M in 11 sales and bought nothing on the open market; 27 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Hollar Jason M. (Chief Executive Officer) sold 44,529 shares on Aug 19, 2026 for $10.5M. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has CAH made?
- 2,609 filings are on EDGAR under the registrant records that have been Cardinal Health Inc., going back to 1994; 1,449 of them are insider ownership forms (Forms 3, 4, 5 and 144).